Open AccessHigh-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers
Author(s) -
Mutahir A. Tunio,
Mansoor Rafi,
Altaf Hashmi,
Rehan Mohsin,
Abdul Qayyum,
M. Hasan,
Amjad Sattar,
Muhammed Mubarak
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i35.4436
Subject(s) - medicine , brachytherapy , total mesorectal excision , colorectal cancer , group b , capecitabine , nuclear medicine , radiation therapy , chemoradiotherapy , stage (stratigraphy) , external beam radiotherapy , urology , surgery , cancer , paleontology , biology
To determine the feasibility and safety of high dose rate intraluminal brachytherapy (HDR-ILBT) boost during preoperative chemoradiation for rectal cancer.